Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 17/12/20151 min de lecture
The Twentieth Food and Drug Administration International Separation Science Society Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products-WCBP 2016
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the International Separation Science Society (CASSS), is announcing a meeting entitled "The Twentieth FDA CASSS Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products--WCBP 2016." The purpose of the meeting is to discuss development of biotechnology- derived drug products and analytic methodologies for the development of biotechnology-derived drug products.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →